$PLYX
Polaryx Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Paramus, NJ
PLYX chart
What traders are saying about $PLYX
Latest postsPolaryx Therapeutics, Inc. news
- Polaryx Therapeutics, Inc. (NASDAQ:PLYX) Stock Has Consensus Target Price of $7.67
MarketBeat ·
- Polaryx Therapeutics, Inc. Estimates – NASDAQ:PLYX
TradingView ·
- Polaryx Therapeutics (NASDAQ:PLYX) Stock Price Down 4.6% - Should You Sell?
MarketBeat ·
- Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
Yahoo Finance ·
- Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
Yahoo Finance ·
- Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
Yahoo Finance ·
- Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
Yahoo Finance ·
- Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
Yahoo Finance ·
- Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
Yahoo Finance ·
- Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
Yahoo Finance ·
- Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
Yahoo Finance ·
- Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Yahoo Finance ·
Polaryx Therapeutics, Inc. key financials
| USD | 2025 | 2024 |
|---|---|---|
| Net income | -$9.0M | -$30.4M |
| Diluted EPS | $-0.20 | $-0.89 |
| Total assets (year end) | $5.2M | $5.0M |
| Cash and equivalents (year end) | $5.1M | $4.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Polaryx Therapeutics, Inc.
- Ticker
- PLYX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Paramus, NJ
- Incorporated in
- WY
- Fiscal year end
- December 31
- SEC CIK
- 2075320
Frequently asked questions
What exchange is Polaryx Therapeutics, Inc. listed on?
Polaryx Therapeutics, Inc. trades on the Nasdaq under the ticker symbol PLYX.
What industry is Polaryx Therapeutics, Inc. in?
Polaryx Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Polaryx Therapeutics, Inc. headquartered?
Polaryx Therapeutics, Inc.'s business address on file with the SEC is in Paramus, NJ.
When does Polaryx Therapeutics, Inc.'s fiscal year end?
Polaryx Therapeutics, Inc.'s fiscal year ends on December 31.